Your browser doesn't support javascript.
loading
Brain glutamate and sleep efficiency associations following a ketogenic diet intervention in individuals with Alcohol Use Disorder.
Li, Xinyi; Shi, Zhenhao; Byanyima, Juliana; Morgan, Peter T; van der Veen, Jan-Willem; Zhang, Rui; Deneke, Erin; Wang, Gene-Jack; Volkow, Nora D; Wiers, Corinde E.
Afiliação
  • Li X; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Shi Z; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Byanyima J; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Morgan PT; Department of Psychiatry, Yale University, New Haven, CT, 06519, USA.
  • van der Veen JW; Department of Psychiatry, Bridgeport Hospital, Bridgeport, CT, 06610, USA.
  • Zhang R; National Institute of Mental Health, Bethesda, MD, 20892, USA.
  • Deneke E; National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20892, USA.
  • Wang GJ; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Volkow ND; Caron Treatment Centers, 243 N Galen Hall Rd, Wernersville, PA, 19565, USA.
  • Wiers CE; National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20892, USA.
Article em En | MEDLINE | ID: mdl-36311277
Background: We previously showed that ketogenic diet (KD) was effective in curbing alcohol withdrawal and craving in individuals with alcohol use disorder (AUD). We hypothesized that the clinical benefits were due to improvements in sleep. To test this, we performed a secondary analysis on the KD trial data to (1) examine the effects of KD on total sleep time (TST) and sleep quality and (2) investigate the association between KD-induced alterations in cingulate glutamate concentration and changes in TST and sleep quality. Methods: AUD individuals undergoing alcohol detoxification were randomized to receive KD (n=19) or standard American diet (SA; n=14) for three weeks. TST was measured weekly by self-report, GENEActive sleep accelerometer, and X4 Sleep Profiler ambulatory device. Sleep quality was assessed using subjectively ratings of sleep depth and restedness and Sleep Profiler (Sleep Efficiency [%]). Weekly 1H magnetic resonance spectroscopy scans measured cingulate glutamate levels. Results: TST was lower in KD than SA and increased with effect of time. Sleep depth, restedness, and Sleep Efficiency improved with time, but exhibited no effect of diet. In KD and SA combined, week 1 cingulate glutamate levels correlated positively with Sleep Efficiency, but not with TST. Conclusions: Although cingulate glutamate levels correlated positively with Sleep Efficiency in week 1, KD-induced glutamate elevation did not produce significant sleep improvements. Rather, KD was associated with lower TST than SA. Given the well-established associations between sleep and alcohol relapse, longer follow up assessment of KD's impact on sleep in AUD is warranted.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article